2013 Q4 Form 10-K Financial Statement
#000137633914000005 Filed on March 04, 2014
Income Statement
Concept | 2013 Q4 | 2013 | 2012 Q4 |
---|---|---|---|
Revenue | $17.99M | $59.18M | $10.51M |
YoY Change | 71.22% | 118.76% | 298.75% |
Cost Of Revenue | $3.110M | $9.328M | $1.690M |
YoY Change | 84.02% | 79.8% | 83.7% |
Gross Profit | $14.88M | $49.85M | $8.820M |
YoY Change | 68.74% | 128.0% | 413.05% |
Gross Profit Margin | 82.71% | 84.24% | 83.93% |
Selling, General & Admin | $14.28M | $46.23M | $8.150M |
YoY Change | 75.21% | 135.96% | 279.07% |
% of Gross Profit | 95.95% | 92.73% | 92.4% |
Research & Development | $1.380M | $4.843M | $1.140M |
YoY Change | 21.05% | 67.87% | 72.73% |
% of Gross Profit | 9.27% | 9.71% | 12.93% |
Depreciation & Amortization | $480.0K | $637.0K | $380.0K |
YoY Change | 26.32% | 36.99% | -17.39% |
% of Gross Profit | 3.23% | 1.28% | 4.31% |
Operating Expenses | $15.93M | $51.07M | $9.790M |
YoY Change | 62.72% | 127.22% | 135.9% |
Operating Profit | -$1.047M | -$2.639M | -$970.0K |
YoY Change | 7.94% | -50.73% | -60.1% |
Interest Expense | -$10.00K | $45.00K | -$630.0K |
YoY Change | -98.41% | -92.41% | 350.0% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$1.420M | -$4.012M | -$1.610M |
YoY Change | -11.8% | -47.64% | -37.6% |
Income Tax | $0.00 | $100.0K | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$1.427M | -$4.112M | -$1.605M |
YoY Change | -11.09% | -46.34% | -37.72% |
Net Earnings / Revenue | -7.93% | -6.95% | -15.27% |
Basic Earnings Per Share | -$0.01 | -$0.04 | -$0.01 |
Diluted Earnings Per Share | -$0.01 | -$0.04 | -$0.01 |
COMMON SHARES | |||
Basic Shares Outstanding | 97.85M shares | 96.29M shares | |
Diluted Shares Outstanding | 96.29M shares |
Balance Sheet
Concept | 2013 Q4 | 2013 | 2012 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $44.10M | $44.10M | $6.800M |
YoY Change | 548.53% | 548.53% | 65.85% |
Cash & Equivalents | $44.08M | $44.10M | $6.754M |
Short-Term Investments | |||
Other Short-Term Assets | $1.300M | $1.300M | $700.0K |
YoY Change | 85.71% | 85.71% | 250.0% |
Inventory | $3.881M | $3.900M | $3.023M |
Prepaid Expenses | |||
Receivables | $16.09M | $16.10M | $7.654M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $65.39M | $65.40M | $18.09M |
YoY Change | 261.49% | 261.33% | 162.16% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.086M | $4.100M | $1.072M |
YoY Change | 281.29% | 272.73% | 19.07% |
Goodwill | $4.040M | $4.040M | |
YoY Change | -0.01% | ||
Intangibles | $11.18M | $11.91M | |
YoY Change | -6.15% | -21.06% | |
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $70.00K | |
YoY Change | -100.0% | -65.0% | |
Total Long-Term Assets | $19.31M | $19.30M | $17.09M |
YoY Change | 12.94% | 12.87% | -15.38% |
TOTAL ASSETS | |||
Total Short-Term Assets | $65.39M | $65.40M | $18.09M |
Total Long-Term Assets | $19.31M | $19.30M | $17.09M |
Total Assets | $84.69M | $84.70M | $35.18M |
YoY Change | 140.73% | 140.63% | 29.83% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.491M | $2.500M | $1.252M |
YoY Change | 98.97% | 92.31% | -16.55% |
Accrued Expenses | $1.406M | $7.000M | $990.7K |
YoY Change | 41.92% | 89.19% | 23.84% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $9.608M | $9.600M | $5.017M |
YoY Change | 91.5% | 92.0% | 6.75% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $4.012M |
YoY Change | -100.0% | -100.0% | 48.61% |
Other Long-Term Liabilities | $1.518M | $1.500M | $353.3K |
YoY Change | 329.62% | -75.41% | -95.41% |
Total Long-Term Liabilities | $1.518M | $1.500M | $4.366M |
YoY Change | -65.23% | -85.15% | -58.02% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $9.608M | $9.600M | $5.017M |
Total Long-Term Liabilities | $1.518M | $1.500M | $4.366M |
Total Liabilities | $11.13M | $11.10M | $15.18M |
YoY Change | -26.68% | -26.97% | -0.16% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$73.80M | -$69.68M | |
YoY Change | 5.9% | ||
Common Stock | $104.0K | $88.42K | |
YoY Change | 17.62% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $25.00K | $25.00K | |
YoY Change | 0.0% | ||
Treasury Stock Shares | 50.00K shares | 50.00K shares | |
Shareholders Equity | $73.57M | $73.60M | $20.01M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $84.69M | $84.70M | $35.18M |
YoY Change | 140.73% | 140.63% | 29.83% |
Cashflow Statement
Concept | 2013 Q4 | 2013 | 2012 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.427M | -$4.112M | -$1.605M |
YoY Change | -11.09% | -46.34% | -37.72% |
Depreciation, Depletion And Amortization | $480.0K | $637.0K | $380.0K |
YoY Change | 26.32% | 36.99% | -17.39% |
Cash From Operating Activities | $830.0K | -$284.0K | -$870.0K |
YoY Change | -195.4% | -91.48% | -47.27% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$500.0K | -$3.030M | -$240.0K |
YoY Change | 108.33% | 373.44% | 242.86% |
Acquisitions | $0.00 | ||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | -$500.0K | -$3.026M | -$240.0K |
YoY Change | 108.33% | 375.04% | -233.33% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 37.66M | $40.63M | 240.0K |
YoY Change | 15591.67% | 514.74% | -95.15% |
NET CHANGE | |||
Cash From Operating Activities | 830.0K | -$284.0K | -870.0K |
Cash From Investing Activities | -500.0K | -$3.026M | -240.0K |
Cash From Financing Activities | 37.66M | $40.63M | 240.0K |
Net Change In Cash | 37.99M | $37.32M | -870.0K |
YoY Change | -4466.67% | 1313.25% | -125.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | $830.0K | -$284.0K | -$870.0K |
Capital Expenditures | -$500.0K | -$3.030M | -$240.0K |
Free Cash Flow | $1.330M | $2.746M | -$630.0K |
YoY Change | -311.11% | -202.01% | -60.13% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
89627601 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
1251684 | USD |
CY2013Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
2490531 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7653561 | USD |
CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
16092836 | USD |
CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1405974 | USD |
CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
990697 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2301870 | USD |
CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2279840 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
147284219 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
|
2715552 | USD |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2538721 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6009176 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1659083 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
47733 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
14885 | USD |
CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2538721 | USD |
CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6009176 | USD |
CY2011 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1659083 | USD |
CY2011 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | USD |
CY2013 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
27236 | USD |
CY2012 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
20449 | USD |
CY2013 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1328439 | USD |
CY2011 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
315152 | USD |
CY2012 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1714101 | USD |
CY2011 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1335908 | USD |
CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1053971 | USD |
CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
22056948 | shares |
CY2012 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1380241 | USD |
CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27372173 | shares |
CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
16660776 | shares |
CY2012Q4 | us-gaap |
Assets
Assets
|
35182608 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
84693893 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
65388771 | USD |
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
18088791 | USD |
CY2011 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | USD |
CY2012 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
84650 | USD |
CY2013 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
355144 | USD |
CY2011 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
33583 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
44077751 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6754485 | USD |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4112326 | USD |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1340922 | USD |
CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2771404 | USD |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
37323266 | USD |
CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2642159 | USD |
CY2010Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
CY2013Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
43600000 | USD |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
130000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
130000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
88423169 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
104425614 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
88373169 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
104375614 | shares |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
88423 | USD |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
104426 | USD |
CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Market Concentrations and Credit Risk</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States.  In July 2010, the Federal Deposit Insurance Corporation (“FDIC”) increased coverage to </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> for substantially all depository accounts. As of December 31, 2013, the Company had cash and cash equivalents of approximately </font><font style="font-family:inherit;font-size:10pt;">$43,600,000</font><font style="font-family:inherit;font-size:10pt;"> in excess of the insured amounts.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s principal market concentration of risk is related to its limited distribution channels.  The Company's revenues include the distribution efforts of several independent companies as well as the Company's internal sales force. Significant revenues are derived from its relationships with </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> of its distributors, AvKARE, Inc. which sells our products to the Federal government and another distributor that sells our products in certain defined Territories. For the years ended December 31, 2013, 2012 and 2011, AvKARE revenue was </font><font style="font-family:inherit;font-size:10pt;">56%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">40%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. Related receivables for the same time periods were </font><font style="font-family:inherit;font-size:10pt;">55%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">53%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">0%</font><font style="font-family:inherit;font-size:10pt;">, of total accounts receivable, respectively. For the years ended December 31, 2013, 2012 and 2011, the other distributor's revenue was </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. Related receivables for the same time periods were </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable, respectively.</font></div></div> | |
CY2013Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
0 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
0 | USD |
CY2012Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
5313645 | USD |
CY2011 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
80000 | USD |
CY2012 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
514456 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation
ContractualObligation
|
6430141 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
|
1421135 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
|
1379877 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
|
869841 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
|
1300289 | USD |
CY2013Q4 | us-gaap |
Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
|
1339418 | USD |
CY2012Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
4012442 | USD |
CY2012 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
5188378 | USD |
CY2011 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
3357909 | USD |
CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
9328114 | USD |
CY2013 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
0 | USD |
CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
CY2012Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1301203 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
3000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
1000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1021000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1117000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
18368303 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
20244000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2011Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.3805 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
15539000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
14663000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
89000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
-507000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1369000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1407356 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
213000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2151000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
-125000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
1404000 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
20244000 | USD |
CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
18368303 | USD |
CY2013 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.06 | |
CY2013 | us-gaap |
Depreciation
Depreciation
|
637246 | USD |
CY2011 | us-gaap |
Depreciation
Depreciation
|
446502 | USD |
CY2012 | us-gaap |
Depreciation
Depreciation
|
465367 | USD |
CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.09 | |
CY2011 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.14 | |
CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.04 | |
CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2011Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
CY2011Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2011Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.04 | |
CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.00 | |
CY2012Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0248 | |
CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.4673 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.1273 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0065 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0340 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.0248 | |
CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2753237 | USD |
CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
5588811 | USD |
CY2013Q4 | us-gaap |
Gross Profit
GrossProfit
|
14882616 | USD |
CY2013Q2 | us-gaap |
Gross Profit
GrossProfit
|
11316261 | USD |
CY2012Q1 | us-gaap |
Gross Profit
GrossProfit
|
2746953 | USD |
CY2012Q4 | us-gaap |
Gross Profit
GrossProfit
|
8820402 | USD |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
12052935 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
5740131 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
923935 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
824335 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
834302 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
923935 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
923935 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
10170573 | USD |
CY2012 | us-gaap |
Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
|
0 | USD |
CY2013 | us-gaap |
Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
|
-36800 | USD |
CY2011 | us-gaap |
Gain Loss On Disposition Of Property
GainLossOnDispositionOfProperty
|
0 | USD |
CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
4040443 | USD |
CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
4040443 | USD |
CY2013 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
30000 | USD |
CY2011 | us-gaap |
Gross Profit
GrossProfit
|
4402537 | USD |
CY2013 | us-gaap |
Gross Profit
GrossProfit
|
49852620 | USD |
CY2012 | us-gaap |
Gross Profit
GrossProfit
|
21865395 | USD |
CY2011Q3 | us-gaap |
Gross Profit
GrossProfit
|
1265584 | USD |
CY2012Q2 | us-gaap |
Gross Profit
GrossProfit
|
3769330 | USD |
CY2012Q3 | us-gaap |
Gross Profit
GrossProfit
|
6528710 | USD |
CY2013Q3 | us-gaap |
Gross Profit
GrossProfit
|
14002270 | USD |
CY2011Q1 | us-gaap |
Gross Profit
GrossProfit
|
333370 | USD |
CY2011Q2 | us-gaap |
Gross Profit
GrossProfit
|
1084458 | USD |
CY2013Q1 | us-gaap |
Gross Profit
GrossProfit
|
9651473 | USD |
CY2011Q4 | us-gaap |
Gross Profit
GrossProfit
|
1719125 | USD |
CY2013Q4 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
368000 | USD |
CY2012 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
1800000 | USD |
CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4012239 | USD |
CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-10193986 | USD |
CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-7662376 | USD |
CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
99614 | USD |
CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2012 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2011 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
61129 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1208747 | USD |
CY2011 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
732938 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-81112 | USD |
CY2011 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1208456 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
8439275 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5761642 | USD |
CY2012 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
605856 | USD |
CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
352881 | USD |
CY2011 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
328379 | USD |
CY2013 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
2835574 | USD |
CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
3022784 | USD |
CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
3880776 | USD |
CY2012 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
2354888 | USD |
CY2011 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
194934 | USD |
CY2011 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
107886 | USD |
CY2012 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
387896 | USD |
CY2013 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-41641 | USD |
CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
857992 | USD |
CY2011 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
253942 | USD |
CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2310182 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-70000 | USD |
CY2012 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-96657 | USD |
CY2011 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
80375 | USD |
CY2011 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
16383 | USD |
CY2012 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
40840 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-28969 | USD |
CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
466060 | USD |
CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
70980 | USD |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
706683 | USD |
CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
11911749 | USD |
CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
11178573 | USD |
CY2012 | us-gaap |
Interest Expense
InterestExpense
|
592892 | USD |
CY2013 | us-gaap |
Interest Expense
InterestExpense
|
45233 | USD |
CY2011 | us-gaap |
Interest Expense
InterestExpense
|
117818 | USD |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
36202 | USD |
CY2011 | us-gaap |
Interest Paid
InterestPaid
|
15456 | USD |
CY2012 | us-gaap |
Interest Paid
InterestPaid
|
13322 | USD |
CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1048886 | USD |
CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1349121 | USD |
CY2012Q4 | us-gaap |
Inventory Gross
InventoryGross
|
3181405 | USD |
CY2013Q4 | us-gaap |
Inventory Gross
InventoryGross
|
4203004 | USD |
CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
233747 | USD |
CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
202414 | USD |
CY2012Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
158621 | USD |
CY2013Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
322228 | USD |
CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1598537 | USD |
CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
2951704 | USD |
CY2011 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
488000 | USD |
CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
485000 | USD |
CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1000000 | USD |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
11125823 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
15175306 | USD |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
35182608 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
84693893 | USD |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5017201 | USD |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9607867 | USD |
CY2012Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
4012442 | USD |
CY2013Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
0 | USD |
CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MiMedx Group, Inc. (“MiMedx,” "the Company,” “we,” or “us”) operates in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> business segment, Regenerative Biomaterials, which includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.  Our biomaterial platform technologies include tissue technologies, AmnioFix® and EpiFix®, and device technology CollaFix</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> .</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is focused primarily on the United States but will pursue other individual markets based upon the specific opportunity.  The adoption of the technologies may vary depending on each country’s regulations, but the opportunities to help individuals in the different disease states remain similar and large.</font></div></div> | |
CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6609921 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10138683 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
40634157 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3025414 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-636502 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-702508 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3331260 | USD |
CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6664771 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-285477 | USD |
CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10193986 | USD |
CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7662376 | USD |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4111853 | USD |
CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1426938 | USD |
CY2011Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3347562 | USD |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4219372 | USD |
CY2011Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1765723 | USD |
CY2011Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2503505 | USD |
CY2011Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2577196 | USD |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1620408 | USD |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-307118 | USD |
CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-757389 | USD |
CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1605283 | USD |
CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-744069 | USD |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1093652 | USD |
CY2013 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | Business_Segment |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2638567 | USD |
CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5355383 | USD |
CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9761016 | USD |
CY2013 | us-gaap |
Operating Loss Carryforwards Expiration Dates
OperatingLossCarryforwardsExpirationDates
|
2027 and 2033 | |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
70000 | USD |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
0 | USD |
CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
122551 | USD |
CY2012Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
21583 | USD |
CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
353333 | USD |
CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1517956 | USD |
CY2012 | us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
568 | USD |
CY2011 | us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
0 | USD |
CY2013 | us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
0 | USD |
CY2011 | us-gaap |
Payments For Tenant Improvements
PaymentsForTenantImprovements
|
0 | USD |
CY2013 | us-gaap |
Payments For Tenant Improvements
PaymentsForTenantImprovements
|
996866 | USD |
CY2012 | us-gaap |
Payments For Tenant Improvements
PaymentsForTenantImprovements
|
0 | USD |
CY2013 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
101694 | USD |
CY2011 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2012 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2011 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
466417 | USD |
CY2013 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2012 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2011 | us-gaap |
Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
|
0 | USD |
CY2013 | us-gaap |
Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
|
57450 | USD |
CY2012 | us-gaap |
Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
|
16116 | USD |
CY2013 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
2336517 | USD |
CY2012 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
636502 | USD |
CY2011 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
486091 | USD |
CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1337408 | USD |
CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
657961 | USD |
CY2013 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Certain amounts in the prior year financial statements have been reclassified to conform to the current year financial statement presentation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div> | |
CY2011 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
3730587 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
0 | USD |
CY2011 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
1250000 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
36602306 | USD |
CY2012 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
CY2011 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
CY2011 | us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
5000000 | USD |
CY2012 | us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
0 | USD |
CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1052668 | USD |
CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1981418 | USD |
CY2011 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
295753 | USD |
CY2012 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
6001063 | USD |
CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2107883 | USD |
CY2011 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3351465 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6387976 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4086106 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1071625 | USD |
CY2011Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
2152094 | USD |
CY2013 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
70141 | USD |
CY2012 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
201812 | USD |
CY2011 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
92565 | USD |
CY2012 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
427126 | USD |
CY2013 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
CY2011 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
CY2011 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
99000 | USD |
CY2012 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2011 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
7760446 | USD |
CY2013 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
59180734 | USD |
CY2012 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
27053773 | USD |
CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
11556493 | USD |
CY2013Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
16115708 | USD |
CY2013Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
17993790 | USD |
CY2012Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
4884256 | USD |
CY2011Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1043487 | USD |
CY2012Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
3705808 | USD |
CY2011Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
2635466 | USD |
CY2013Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
13514743 | USD |
CY2011 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
88657 | USD |
CY2012 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2976313 | USD |
CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2884546 | USD |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4843457 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-73795575 | USD |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-69683722 | USD |
CY2013 | us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Grant Income</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company received a Regional Economic Business Assistance ("REBA") grant in the amount of </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> from the State of Georgia to help the Company defray certain expenses and capital expenditures related to the Company's expansion of manufacturing activities in the State.  In order to retain the grant monies the Company was required to add a certain number of full time positions and spend a certain amount on capital and operations expenditures by December 31, 2014. As of December 31, 2013, the Company had satisfied the grant requirements. Accordingly, the Company has recorded the </font><font style="font-family:inherit;font-size:10pt;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> as a reduction of Selling, General and Administrative expenses in the accompanying Consolidated Statements of Operations. Previously, this amount was recorded as Deferred Grant Income and was included in Other Liabilities per ASC 450-30 Gain Contingencies.</font></div></div> | |
CY2013 | us-gaap |
Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products primarily through a combination of a direct sales force, independent stocking distributors and third party representatives in the U.S. and independent distributors in international markets.  The Company recognizes revenue when title to the goods and risk of loss transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance.  In cases where the Company utilizes distributors or ships products directly to the end user, it recognizes revenue according to the shipping terms of the agreement provided all revenue recognition criteria have been met.  A portion of the Company’s revenue is generated from inventory maintained at hospitals or with field representatives.  For these products, revenue is recognized at the time the product has been used or implanted.  The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.</font></div></div> | |
CY2012Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
7954046 | USD |
CY2011Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1929399 | USD |
CY2012Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
10509663 | USD |
CY2011 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
9845529 | USD |
CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
46225657 | USD |
CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
19590446 | USD |
CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2538721 | USD |
CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1659083 | USD |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6009176 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0224 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0188 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0177 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0062 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0086 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0085 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
6000000 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
22500000 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
15081653 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.33 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
718978 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
8864115 | USD |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
258000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
35499 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
265002 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
4021000 | shares |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.63 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.08 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.07 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
96614260 | USD |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
13614135 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
15375960 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.42 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.46 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
95324825 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
6807732 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
2.42 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
50441475 | USD |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
|
1194000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
|
3351000 | USD |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue
|
1851000 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.01 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1.11 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.47 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.31 | |
CY2013Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
6807732 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
15375960 | shares |
CY2011 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P6Y6M | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y8M12D | |
CY2013Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
1.33 | |
CY2013Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
2.46 | |
CY2013 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P7Y8M12D | |
CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2011 | us-gaap |
Stock Issued1
StockIssued1
|
7087500 | USD |
CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2011 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
893267 | shares |
CY2013 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
893267 | shares |
CY2012 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
893267 | shares |
CY2013 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
5272004 | shares |
CY2011 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
406664 | shares |
CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1958674 | shares |
CY2012 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
893267 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
5272004 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
406663 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
36509810 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3730587 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1052668 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
295753 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1981418 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20007302 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
73568070 | USD |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11896565 | USD |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6100528 | USD |
CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
50000 | shares |
CY2012Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
50000 | shares |
CY2012Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
25000 | USD |
CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
25000 | USD |
CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported consolidated statements of operations during the reporting period.  Actual results could differ from those estimates.</font></div></div> | |
CY2011 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2012 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2013 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
72450337 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
96285504 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
81646295 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
96285504 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
81646295 | shares |
CY2011 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
72450337 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
81646295 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
96285504 | shares |
CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
72450337 | shares |
CY2012 | mdxg |
Adjustments To Additional Paid In Capital Related Party
AdjustmentsToAdditionalPaidInCapitalRelatedParty
|
514456 | USD |
CY2011 | mdxg |
Adjustments To Additional Paid In Capital Related Party
AdjustmentsToAdditionalPaidInCapitalRelatedParty
|
80000 | USD |
CY2011 | mdxg |
Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
|
14885 | USD |
CY2013 | mdxg |
Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
|
0 | USD |
CY2012 | mdxg |
Beneficial Conversion Feature Related To Warrants Issued With Regard To Senior Secured Promissory Notes
BeneficialConversionFeatureRelatedToWarrantsIssuedWithRegardToSeniorSecuredPromissoryNotes
|
0 | USD |
CY2012 | mdxg |
Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
|
216 | USD |
CY2011 | mdxg |
Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
|
0 | USD |
CY2013 | mdxg |
Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
|
0 | USD |
CY2013Q4 | mdxg |
Contractual Obligation Due After Second Year
ContractualObligationDueAfterSecondYear
|
119581 | USD |
CY2011 | mdxg |
Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
|
437500 | USD |
CY2012 | mdxg |
Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
|
0 | USD |
CY2013 | mdxg |
Convertible Debt Issued In Acquisition Of Company
ConvertibleDebtIssuedInAcquisitionOfCompany
|
0 | USD |
CY2012Q4 | mdxg |
Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
|
567947 | USD |
CY2013Q4 | mdxg |
Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
|
0 | USD |
CY2012Q4 | mdxg |
Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
|
6000 | USD |
CY2013Q4 | mdxg |
Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
|
142000 | USD |
CY2012Q4 | mdxg |
Deferred Tax Liability Debt Instrument Convertible Beneficial Conversion Feature
DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature
|
449000 | USD |
CY2013Q4 | mdxg |
Deferred Tax Liability Debt Instrument Convertible Beneficial Conversion Feature
DeferredTaxLiabilityDebtInstrumentConvertibleBeneficialConversionFeature
|
0 | USD |
CY2013 | mdxg |
Defined Benefit Plan Maximum Pre Tax Contributions By Plan Participants
DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants
|
5500 | USD |
CY2013 | mdxg |
Defined Contribution Plan Maximum Percentage Of Eligible Wages Deferred By Participants
DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants
|
1 | |
CY2013Q4 | mdxg |
Earn Out Liability Payable In Mimedx Stock
EarnOutLiabilityPayableInMimedxStock
|
0 | USD |
CY2012Q4 | mdxg |
Earn Out Liability Payable In Mimedx Stock
EarnOutLiabilityPayableInMimedxStock
|
5792330 | USD |
CY2013 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
|
0 | USD |
CY2012 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
|
1567050 | USD |
CY2011 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarn-OutLiability
|
5803 | USD |
CY2012 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
|
1567050 | USD |
CY2011 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
|
5803 | USD |
CY2013 | mdxg |
Fair Value Adjustment Of Earn Out Liability
FairValueAdjustmentOfEarnOutLiability
|
0 | USD |
CY2011 | mdxg |
Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
|
0 | USD |
CY2013 | mdxg |
Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
|
368102 | USD |
CY2012 | mdxg |
Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
|
1798495 | USD |
CY2012Q4 | mdxg |
Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
|
6647251 | USD |
CY2013Q4 | mdxg |
Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
|
8069324 | USD |
CY2012Q4 | mdxg |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
18559000 | USD |
CY2011 | mdxg |
Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
|
2278052 | USD |
CY2013 | mdxg |
Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
|
0 | USD |
CY2013Q4 | mdxg |
Number Of Major Customers
NumberOfMajorCustomers
|
2 | distributor |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled Or Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredInPeriod
|
265002 | shares |
CY2013Q4 | mdxg |
Long Term Debt Including Related Party Current Maturities
LongTermDebtIncludingRelatedPartyCurrentMaturities
|
0 | USD |
CY2013 | mdxg |
Maximum Eligible Wages Deferred By Participants Per Year
MaximumEligibleWagesDeferredByParticipantsPerYear
|
17500 | USD |
CY2013 | mdxg |
Minimum Age For Additional Contribution Beyond Normal Plan
MinimumAgeForAdditionalContributionBeyondNormalPlan
|
P50Y | |
CY2013 | mdxg |
Minimum Age Require To Qualify For Pension Plan
MinimumAgeRequireToQualifyForPensionPlan
|
P21Y | |
CY2013 | mdxg |
Minimum Service Period Require To Qualify For Pension Plan
MinimumServicePeriodRequireToQualifyForPensionPlan
|
P3M | |
CY2012 | mdxg |
Noncash Stock Issued Acquisition
NoncashStockIssuedAcquisition
|
893267 | USD |
CY2013Q4 | mdxg |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
19247897 | USD |
CY2012Q4 | mdxg |
Long Term Debt Including Related Party Current Maturities
LongTermDebtIncludingRelatedPartyCurrentMaturities
|
0 | USD |
CY2013 | mdxg |
Number Of Share Based Compensation Plans
NumberOfShareBasedCompensationPlans
|
3 | plan |
CY2013Q4 | mdxg |
Outstanding Assumed Options
OutstandingAssumedOptions
|
375000 | shares |
CY2012 | mdxg |
Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
|
0 | USD |
CY2013 | mdxg |
Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
|
688897 | USD |
CY2011 | mdxg |
Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
|
0 | USD |
CY2011 | mdxg |
Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
|
1300000 | USD |
CY2013 | mdxg |
Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
|
0 | USD |
CY2012 | mdxg |
Proceeds From Line Of Credit With Related Party
ProceedsFromLineOfCreditWithRelatedParty
|
0 | USD |
CY2013 | mdxg |
Proceeds From Reba Grant
ProceedsFromRebaGrant
|
0 | USD |
CY2011 | mdxg |
Proceeds From Reba Grant
ProceedsFromRebaGrant
|
250000 | USD |
CY2012 | mdxg |
Proceeds From Reba Grant
ProceedsFromRebaGrant
|
0 | USD |
CY2012 | mdxg |
Repurchase Of Warrants
RepurchaseOfWarrants
|
568 | USD |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Cancelled Or Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsCancelledOrExpiredWeightedAverageGrantDateFairValue
|
2.14 | |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriod
|
4021000 | shares |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.08 | |
CY2013Q4 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber
|
8568228 | shares |
CY2012Q4 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedNumber
|
8377538 | shares |
CY2013Q4 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.94 | |
CY2012Q4 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.96 | |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriod
|
3565308 | shares |
CY2013 | mdxg |
Share Based Compensation Arrangement By Share Based Payment Award Stock Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
0.94 | |
CY2011 | mdxg |
Shares Issued In Conjunction With Its Acquisition Of Company
SharesIssuedInConjunctionWithItsAcquisitionOfCompany
|
5250000 | shares |
CY2012 | mdxg |
Stock Issued During Period Shares Accrued Director Fees
StockIssuedDuringPeriodSharesAccruedDirectorFees
|
167086 | shares |
CY2012 | mdxg |
Stock Issued During Period Shares Cashless Exercise
StockIssuedDuringPeriodSharesCashlessExercise
|
216085 | shares |
CY2013 | mdxg |
Stock Issued During Period Shares For Earn Out Liability
StockIssuedDuringPeriodSharesForEarnOutLiability
|
1174915 | shares |
CY2012 | mdxg |
Stock Issued During Period Shares For Earn Out Liability
StockIssuedDuringPeriodSharesForEarnOutLiability
|
2632576 | shares |
CY2012 | mdxg |
Stock Issued During Period Shares Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodSharesIssuedForPaymentOfLineOfCreditWithRelatedParty
|
1403630 | shares |
CY2011 | mdxg |
Stock Issued During Period Value Acquisitions Company
StockIssuedDuringPeriodValueAcquisitionsCompany
|
7087500 | USD |
CY2012 | mdxg |
Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
|
0 | USD |
CY2012 | mdxg |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
6001063 | USD |
CY2013 | mdxg |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
2107883 | USD |
CY2012 | mdxg |
Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
|
184653 | USD |
CY2013 | mdxg |
Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
|
0 | USD |
CY2011 | mdxg |
Stock Issued During Period Value For Accrued Director Fees
StockIssuedDuringPeriodValueForAccruedDirectorFees
|
0 | USD |
CY2012 | mdxg |
Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
|
3185223 | USD |
CY2013 | mdxg |
Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
|
5792330 | USD |
CY2011 | mdxg |
Stock Issued During Period Value For Earn Out Liability
StockIssuedDuringPeriodValueForEarnOutLiability
|
0 | USD |
CY2012 | mdxg |
Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
|
1403630 | USD |
CY2013 | mdxg |
Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
|
0 | USD |
CY2011 | mdxg |
Stock Issued During Period Value Issued For Payment Of Line Of Credit With Related Party
StockIssuedDuringPeriodValueIssuedForPaymentOfLineOfCreditWithRelatedParty
|
0 | USD |
CY2013 | mdxg |
Warrants Term
WarrantsTerm
|
P5Y | |
CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
CY2013 | dei |
Document Type
DocumentType
|
10-K | |
CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001376339 | |
CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
105581111 | shares |
CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
559000000 | USD |
CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
MIMEDX GROUP, INC. | |
CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No |